Stocks Overview

LAST PRICE
37.4100
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
35.0000/ 1
Ask / Lots
50.0000/ 1
Open / Previous Close
37.7300 / 37.4100
Day Range
Low 37.0800
High 37.7500
52 Week Range
Low 27.9850
High 50.9900
Volume
387,347
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Friday's close: 37.49
Time	Volume	XENE
09:32 ET	964	37.68
09:43 ET	300	37.55
09:48 ET	400	37.44
09:50 ET	100	37.08
09:52 ET	400	37.39
09:54 ET	400	37.39
09:56 ET	100	37.27
09:57 ET	3872	37.47
09:59 ET	400	37.5
10:01 ET	100	37.41
10:03 ET	1190	37.4
10:06 ET	1380	37.38
10:08 ET	100	37.4
10:10 ET	100	37.49
10:12 ET	200	37.44
10:14 ET	780	37.5
10:17 ET	100	37.39
10:19 ET	200	37.51
10:24 ET	100	37.49
10:26 ET	105	37.605
10:28 ET	865	37.42
10:30 ET	200	37.51
10:32 ET	400	37.46
10:33 ET	100	37.45
10:35 ET	499	37.53
10:37 ET	1336	37.71
10:39 ET	100	37.61
10:42 ET	100	37.62
10:44 ET	100	37.605
10:46 ET	100	37.64
10:50 ET	400	37.6
10:51 ET	100	37.57
10:53 ET	100	37.52
10:55 ET	100	37.7
10:57 ET	400	37.71
11:00 ET	100	37.67
11:02 ET	200	37.66
11:04 ET	300	37.58
11:06 ET	2800	37.48
11:08 ET	4683	37.5
11:09 ET	100	37.43
11:11 ET	200	37.44
11:13 ET	100	37.53
11:15 ET	300	37.6
11:20 ET	100	37.62
11:22 ET	200	37.61
11:24 ET	100	37.6
11:27 ET	100	37.6
11:29 ET	100	37.59
11:31 ET	20500	37.74
11:33 ET	600	37.59
11:38 ET	100	37.55
11:40 ET	700	37.55
11:42 ET	100	37.56
11:44 ET	200	37.59
11:45 ET	200	37.49
11:49 ET	100	37.49
11:51 ET	100	37.49
11:54 ET	100	37.57
11:56 ET	100	37.5
11:58 ET	500	37.565
12:02 ET	100	37.51
12:03 ET	100	37.52
12:07 ET	300	37.51
12:09 ET	236	37.5
12:12 ET	600	37.495
12:14 ET	200	37.515
12:16 ET	1900	37.4948
12:18 ET	1399	37.54
12:20 ET	2197	37.49
12:21 ET	113	37.475
12:23 ET	500	37.43
12:25 ET	100	37.36
12:27 ET	100	37.34
12:30 ET	600	37.46
12:32 ET	2457	37.47
12:34 ET	300	37.5
12:36 ET	700	37.54
12:38 ET	7877	37.5
12:39 ET	600	37.51
12:41 ET	100	37.5
12:43 ET	400	37.52
12:48 ET	200	37.54
12:50 ET	100	37.53
12:52 ET	1695	37.595
12:54 ET	800	37.55
12:56 ET	700	37.49
12:57 ET	200	37.525
12:59 ET	600	37.505
01:03 ET	200	37.5
01:06 ET	500	37.51
01:10 ET	600	37.445
01:12 ET	400	37.43
01:14 ET	100	37.475
01:15 ET	300	37.46
01:17 ET	100	37.44
01:19 ET	350	37.49
01:21 ET	341	37.43
01:24 ET	330	37.33
01:26 ET	232	37.395
01:28 ET	700	37.42
01:30 ET	436	37.49
01:33 ET	500	37.45
01:35 ET	430	37.375
01:37 ET	200	37.41
01:39 ET	100	37.37
01:42 ET	1204	37.48
01:44 ET	300	37.41
01:46 ET	300	37.46
01:48 ET	1100	37.545
01:50 ET	400	37.5425
01:51 ET	200	37.52
01:55 ET	26600	37.62
01:57 ET	680	37.53
02:00 ET	300	37.49
02:02 ET	300	37.48
02:04 ET	412	37.485
02:06 ET	500	37.54
02:08 ET	700	37.5
02:09 ET	800	37.58
02:11 ET	100	37.6
02:13 ET	100	37.54
02:15 ET	100	37.53
02:20 ET	9506	37.59
02:22 ET	2172	37.63
02:24 ET	100	37.63
02:26 ET	100	37.57
02:27 ET	300	37.595
02:29 ET	400	37.63
02:31 ET	500	37.63
02:33 ET	1100	37.67
02:36 ET	400	37.67
02:38 ET	100	37.72
02:40 ET	300	37.62
02:42 ET	300	37.66
02:44 ET	100	37.66
02:45 ET	600	37.59
02:47 ET	200	37.62
02:49 ET	900	37.66
02:54 ET	500	37.5
02:58 ET	100	37.57
03:00 ET	2857	37.56
03:02 ET	2212	37.49
03:03 ET	100	37.54
03:07 ET	1450	37.31
03:09 ET	2000	37.385
03:12 ET	279	37.385
03:14 ET	100	37.39
03:16 ET	400	37.42
03:18 ET	760	37.405
03:20 ET	100	37.405
03:21 ET	1115	37.47
03:23 ET	400	37.52
03:25 ET	2249	37.495
03:27 ET	1100	37.53
03:30 ET	200	37.51
03:32 ET	300	37.495
03:34 ET	200	37.5
03:36 ET	2400	37.47
03:38 ET	500	37.46
03:39 ET	400	37.465
03:41 ET	600	37.49
03:43 ET	600	37.495
03:45 ET	1100	37.49
03:48 ET	1100	37.5
03:50 ET	3094	37.43
03:52 ET	3871	37.47
03:54 ET	1100	37.49
03:56 ET	5327	37.39
03:57 ET	4713	37.36
03:59 ET	10734	37.41

Data delayed at least 15 minutes.

Jun 18, 2024
- DJ Xenon Pharmaceuticals Price Target Maintained With a $55.00/Share by RBC Capital, from 8:59AM ET on Tuesday Jun 18, 2024 by Dow Jones
  8:59AM ET on Tuesday Jun 18, 2024 by Dow Jones
Jun 5, 2024
- Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference, from 4:01PM ET on Wednesday Jun 05, 2024 by Dow Jones
  4:01PM ET on Wednesday Jun 05, 2024 by Dow Jones
May 28, 2024
- Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting, from 8:30AM ET on Tuesday May 28, 2024 by Dow Jones
  8:30AM ET on Tuesday May 28, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesXENE Xenon Pharmaceuticals Inc	2.8B	-13.8x	---
United StatesGERN Geron Corp	2.8B	-13.3x	---
United StatesBHVN Biohaven Ltd	3.0B	-5.1x	---
United StatesIDYA IDEAYA Biosciences Inc	2.8B	-18.5x	---
United StatesSWTX SpringWorks Therapeutics Inc	2.7B	-7.0x	---
United StatesGPCR Structure Therapeutics Inc	2.6B	-18.8x	---
As of 2024-06-25

Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).

Contact Information

Headquarters: 3650 Gilmore WayVANCOUVER, BC, Canada V5G 4W8
Phone: 604-484-3300
Fax: 604-484-3450

Executives

Chairman of the Board: Simon Pimstone
President, Chief Executive Officer, Director: Ian Mortimer
Chief Financial Officer: Sherry Aulin
Executive Vice President - Drug Discovery: James Empfield
Executive Vice President - Strategy and Innovation: Robin Sherrington

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$2.8B
Revenue (TTM)	$0.00
Shares Outstanding	75.5M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	1.26
EPS	$-2.71
Book Value	$12.31
P/E Ratio	-13.8x
Price/Sales (TTM)	---
Price/Cash Flow (TTM)	---
Operating Margin	---

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Xenon Pharmaceuticals Inc
NASDAQ:XENEUnited States

Search Criteria

Charts

Recent News

Jun 18, 2024

DJ Xenon Pharmaceuticals Price Target Maintained With a $55.00/Share by RBC Capital, from 8:59AM ET on Tuesday Jun 18, 2024 by Dow Jones

Jun 5, 2024

Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference, from 4:01PM ET on Wednesday Jun 05, 2024 by Dow Jones

May 28, 2024

Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting, from 8:30AM ET on Tuesday May 28, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar